Moderna Stock News

Moderna, Inc. (NASDAQ:MRNA ) Guggenheim's Inaugural Healthcare Innovation Conference November 12, 2024 10:00 AM ET Company Participants Stephen Hoge - President Conference Call Participants Evan Wang - Guggenheim Securities Evan Wang [Call Starts Abruptly] Inaugural Health Innovation Conference. I'm Evan Wang, one of the senior biotech analysts at Guggenheim.

Here are some of the major companies whose stocks moved on the week's news.

Shares in some of America's largest drug manufacturers tumbled yesterday after President-elect Donald Trump announced Robert F. Kennedy Jr. as his pick for secretary of the Department of Health and Human Services (HHS).

In the 2024 presidential election's latest impact on the stock markets, shares of several vaccine makers were down Friday morning following the nomination of Robert F. Kennedy Jr. to head the Department of Health and Human Services.

Shares of COVID vaccine manufacturers Moderna and Pfizer fell early Friday morning, down 4% and 4.3% respectively.

President Elect Donald Trump called on Robert F. Kennedy Jr. to lead the Department of Health and Human Services. Kennedy is the chairman of anti-vaccine nonprofit Children's Health Defense, and has positioned himself against immunization on several occasions. In response to the nomination, Pfizer Inc (NYSE:PFE) and Moderna Inc (NASDAQ:MRNA) shares are gapping lower.

Over the last few months, much has been said and even more has been speculated on when it comes to how the outcome of the 2024 U.S. presidential election will impact the economy, both global and domestic, as well as wider economic conditions.

Moderna stock and other vaccine shares tumbled Friday morning after Trump picked Kennedy to lead the Department of Health and Human Services. The post Pfizer, Moderna, Novavax Take A Beating After Trump Taps Kennedy To Head Up HHS appeared first on Investor's Business Daily.